Search

everythinglearnresearchcommunity

for

Search:↓

The cancer gene c-Myc increases harmful chemicals that damage DNA and can lead to cancer, but antioxidants can reduce this damage.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

TCDD changes skin cell growth and keratin production in mice.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.

HGF/SF increases skin melanocytes but doesn't change melanin type or amount.

Mutations in the WNT10A gene can cause skin, hair, teeth, and other disorders, and may also affect other areas like kidney and cancer, with potential for targeted treatments.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Removing the Crif1 gene in mouse skin disrupts skin balance and hair growth.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Blocking EGFR in mice causes hair loss and skin changes.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Overexpressing 14-3-3σ in mice skin reduces cell growth and hair density.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

The FGF5 gene variant causes long hair in Akitas, and genetic testing is advised to manage coat length and welfare.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

A new gene mutation caused a man's rare skin condition, Schöpf-Schulz-Passarge syndrome.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

Tet2 and Tet3 enzymes are important for controlling hair growth and shape by affecting gene activity and DNA structure in hair follicles.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.